Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent

Eur J Med Chem. 2016 Feb 15:109:75-88. doi: 10.1016/j.ejmech.2015.12.006. Epub 2015 Dec 10.

Abstract

A series of novel benzamide derivatives, altering the 4-fluorophenylalkyl moiety in cisapride, were synthesized as 5-HT4 receptor agonists, and SAR of these analogs was examined on in vitro and in vivo prokinetic activities. These compounds were synthesized for high 5-HT4 receptor binding affinities and low hERG affinities. Several types of analogs were obtained and screened for 5-HT4 binding, hERG blocking, agonism, and gastric emptying assessment. Among the analogues, compound 23g showed promising results compared with the other analogs with respect to gastric emptying rates in rats. Therefore, we suggest that it may be a clinical candidate for the development of a potent prokinetic agent to treat GI disorders.

Keywords: 5-HT(4); GI disorder; Gastric emptying rate; Prokinetic; hERG inhibition.

MeSH terms

  • Animals
  • Benzamides / chemistry*
  • Benzamides / pharmacology*
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels / metabolism
  • Gastric Emptying / drug effects*
  • Humans
  • Male
  • Piperidines / chemistry*
  • Piperidines / pharmacology*
  • Rats, Sprague-Dawley
  • Receptors, Serotonin, 5-HT4 / metabolism
  • Serotonin 5-HT4 Receptor Agonists / chemistry*
  • Serotonin 5-HT4 Receptor Agonists / pharmacology*
  • Structure-Activity Relationship

Substances

  • Benzamides
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • KCNH2 protein, human
  • Piperidines
  • Serotonin 5-HT4 Receptor Agonists
  • Receptors, Serotonin, 5-HT4